Skip to main content
Clinical Trials/NCT06738472
NCT06738472
Completed
Not Applicable

Efficacy of Home-Based Posture Exercises as an Addition to Pharmacological Treatment in Fibromyalgia

Kirsehir Ahi Evran Universitesi0 sites55 target enrollmentJanuary 25, 2025
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Kirsehir Ahi Evran Universitesi
Enrollment
55
Primary Endpoint
algometry
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

This interventional study aimed to evaluate the effects of home exercise in addition to pharmacological treatment on pain threshold and spinal mobility in fibromyalgia patients.

Detailed Description

Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain, altered pain processing, fatigue, and functional limitations. In addition to pain-related symptoms, individuals with FM frequently present with postural alterations, reduced spinal mobility, and impaired segmental control of the spine, which may contribute to functional disability and reduced quality of life. However, objective assessment of spinal posture and segmental mobility in FM remains limited. This study aims to comprehensively evaluate spinal posture and sagittal plane mobility in patients with fibromyalgia using the Spinal Mouse®, a validated, non-invasive, computer-assisted device that measures spinal curvature and segmental inclination without radiation exposure. The Spinal Mouse allows for reliable assessment of thoracic and lumbar spinal alignment as well as dynamic movement patterns during functional tasks.

Registry
clinicaltrials.gov
Start Date
January 25, 2025
End Date
December 28, 2025
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kirsehir Ahi Evran Universitesi
Responsible Party
Principal Investigator
Principal Investigator

Ömer Faruk ÖZÇELEP

Researcher

Kirsehir Ahi Evran Universitesi

Eligibility Criteria

Inclusion Criteria

  • Participants were between the ages of 18 and 65,
  • No diagnosis of rheumatic disease,
  • No diagnosis of chronic comorbid disease,
  • Participants diagnosed with fibromyalgia syndrome according to the European League Against Rheumatism (EULAR) criteria will be included as volunteers.

Exclusion Criteria

  • Patients under 18, over 65 years of age
  • Those diagnosed with chronic comorbid diseases
  • Those with a history of rheumatic disease

Outcomes

Primary Outcomes

algometry

Time Frame: 4 weeks

spinal mouse

Time Frame: 4 weeks

Secondary Outcomes

  • HADS(4 weeks)
  • PSQI(4 weeks)
  • SF-12(4 weeks)

Similar Trials